Clinical trial

A Study to Evaluate the Safety and Tolerability of EXN407

NCT04565756

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-11-05

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2020-11-05Date precision: day

Registry last updated2025-05-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Macular Edemaunresolved

Interventions

EXN407DRUG

Sponsors & collaborators

Exonate Limitedlead sponsor

Novotech (Australia) Pty Limitedcollaborator

Mapped research locations

MelbourneVictoria, Australia2 SydneyNew South Wales, Australia2 AdelaideSouth Australia, Australia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04565756 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.